Models of Neuroimaging, Biomarkers, and Cognitive in Alzheimer's Disease. Implications for Clinical Trial Design.

Philip Insel

Models of Neuroimaging, Biomarkers, and Cognitive in Alzheimer's Disease. Implications for Clinical Trial Design.

Research output: Thesis › Doctoral Thesis (compilation)

243 Downloads (Pure)

Original language	English
Qualification	Doctor
Awarding Institution	Department of Clinical Sciences, Malmö
Supervisors/Advisors	Mattsson-Carlgren, Niklas, Supervisor Hansson, Oskar, Assistant supervisor Weiner, Michael W, Assistant supervisor, External person
Award date	2021 May 21
Place of Publication	Lund
Publisher	Lund University, Faculty of Medicine
ISBN (Print)	978-91-8021-056-0
Publication status	Published - 2021

Bibliographical note

Defence details
Date: 2021-05-21
Time: 13:00
Place: Segerfalksalen, BMC A10, Sölvegatan 17 i Lund. Join by Zoom: https://lu-se.zoom.us/j/5328347146
External reviewer(s)
Name: Egan, Michael
Title: Vice President
Affiliation: Neuroscience, Global Clinical Development, Merck

Subject classification (UKÄ)

Other Medical Sciences

Access to Document

PhDThesisFinal published version, 11.3 MB

5 Article

Association between Apolipoprotein e ϵ2 vs ϵ4, Age, and β-Amyloid in Adults without Cognitive Impairment
Insel, P. S., Hansson, O. & Mattsson-Carlgren, N., 2021, In: JAMA Neurology. 78, 2, p. 229
Research output: Contribution to journal › Article › peer-review
Time between milestone events in the Alzheimer's disease amyloid cascade
Insel, P. S., Donohue, M. C., Berron, D., Hansson, O. & Mattsson-Carlgren, N., 2021, In: NeuroImage. 227, 117676.
Research output: Contribution to journal › Article › peer-review

Open Access
Determining clinically meaningful decline in preclinical Alzheimer disease
Insel, P. S., Weiner, M., Mackin, R. S., Mormino, E., Lim, Y. Y., Stomrud, E., Palmqvist, S., Masters, C. L., Maruff, P. T., Hansson, O. & Mattsson, N., 2019 Jul 23, In: Neurology. 93, 4, p. e322-e333
Research output: Contribution to journal › Article › peer-review

Open Access

Cite this

@phdthesis{46a58995e22b41bfa120d83e92853762,

title = "Models of Neuroimaging, Biomarkers, and Cognitive in Alzheimer's Disease. Implications for Clinical Trial Design.",

author = "Philip Insel",

note = "Defence details Date: 2021-05-21 Time: 13:00 Place: Segerfalksalen, BMC A10, S{\"o}lvegatan 17 i Lund. Join by Zoom: https://lu-se.zoom.us/j/5328347146 External reviewer(s) Name: Egan, Michael Title: Vice President Affiliation: Neuroscience, Global Clinical Development, Merck",

year = "2021",

language = "English",

isbn = "978-91-8021-056-0",

series = "Lund University, Faculty of Medicine Doctoral Dissertation Series",

publisher = "Lund University, Faculty of Medicine",

number = "2021:50",

type = "Doctoral Thesis (compilation)",

school = "Department of Clinical Sciences, Malm{\"o}",

}

TY - THES

T1 - Models of Neuroimaging, Biomarkers, and Cognitive in Alzheimer's Disease. Implications for Clinical Trial Design.

AU - Insel, Philip

N1 - Defence details Date: 2021-05-21 Time: 13:00 Place: Segerfalksalen, BMC A10, Sölvegatan 17 i Lund. Join by Zoom: https://lu-se.zoom.us/j/5328347146 External reviewer(s) Name: Egan, Michael Title: Vice President Affiliation: Neuroscience, Global Clinical Development, Merck

PY - 2021

Y1 - 2021

M3 - Doctoral Thesis (compilation)

SN - 978-91-8021-056-0

T3 - Lund University, Faculty of Medicine Doctoral Dissertation Series

PB - Lund University, Faculty of Medicine

CY - Lund

ER -

Models of Neuroimaging, Biomarkers, and Cognitive in Alzheimer's Disease. Implications for Clinical Trial Design.

Bibliographical note

Subject classification (UKÄ)

Access to Document

Research output

Association between Apolipoprotein e ϵ2 vs ϵ4, Age, and β-Amyloid in Adults without Cognitive Impairment

Time between milestone events in the Alzheimer's disease amyloid cascade

Determining clinically meaningful decline in preclinical Alzheimer disease

Cite this